Elza Laboratories India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 30-12-2024
- Paid Up Capital ₹ 0.10 M
as on 30-12-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 0.77%
(FY 2023)
- Profit -37.11%
(FY 2023)
- Ebitda 50.05%
(FY 2023)
- Net Worth 11.51%
(FY 2023)
- Total Assets 6.42%
(FY 2023)
About Elza Laboratories India
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Abhi Sharma and Renu Sharma serve as directors at the Company.
- CIN/LLPIN
U74999CH2018PTC041914
- Company No.
041914
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Elza Laboratories India Private Limited offer?
Elza Laboratories India Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Bath Soaps, Skin Lightening Drugs, Glutathione Tablet, Pharma Franchise, Derma Company Franchise, Cosmetics, Lip Cosmetics, Third Party Manufacturing Consultancy, Pharmaceutical Third Party Manufacturing.
Who are the key members and board of directors at Elza Laboratories India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhi Sharma  | Director | 20-Mar-2018 | Current |
| Renu Sharma | Director | 28-May-2018 | Current |
Financial Performance of Elza Laboratories India.
Elza Laboratories India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.77% increase. The company also saw a substantial fall in profitability, with a 37.11% decrease in profit. The company's net worth Soared by an impressive increase of 11.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elza Laboratories India?
Unlock access to Elza Laboratories India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Elza Laboratories India?
Unlock and access historical data on people associated with Elza Laboratories India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elza Laboratories India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elza Laboratories India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
